To determine if a second dose of IL-15 complex could further enhance the efficacy of anti-PD-1 therapy, we next included a second intratumoral injection of IL-15 complex ten days following tumor inoculation (i.e., four days after the first dose of IL-15 complex) (Figure 1D). This evidence concerns the gene IL15 and neoplasm.